Doris Wong Sing Ee 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-04 10:32 am Purchase | 2025-02-26 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | Doris Wong Sing Ee | 12,164,301 70.000% | 12,164,301 (New Position) | Filing |